Title : Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner.

Pub. Date : 2012 Apr

PMID : 22171982






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lenalidomide, an immunomodulator, is clinically effective in CLL and can enhance the anti-CLL effects of CD20 targeting monoclonal antibody, rituximab. Lenalidomide keratin 20 Homo sapiens